Philip Gribbon

Biog:
Philip received his undergraduate and PhD degrees (Biophysics) from Imperial College, London. Following post-doctoral studies at the University of Manchester, he worked on early-stage drug discovery (DD) teams within Pfizer and GlaxoSmithKline. Philip is now at the ESP, a Public Private Partnership that provides DD technology and expertises to academic institutions and consortia.